Endoscopy:结肠镜检查的质量和并发症发生率

2021-07-27 Nebula MedSci原创

治疗性和FIT阳性筛查结肠镜检查的穿孔率和出血率最高

结肠镜检查的推广,大大提高了早期结肠癌的检出率。为了优化结肠镜检查的质量,现已经开发了几种性能指标。这些评估通常不区分结肠镜检查的适应症。

本研究旨在评估两项登记之间联系的可行性:即荷兰的国家结肠镜登记和胃肠道内镜检查不良事件登记,并描述每个适应症的结肠镜质量。

Continuous monitoring of colonoscopy performance in the Netherlands: first results of a nationwide registry

这是一项回顾性研究,采用了荷兰胃肠内镜检查 (DGEA) 和荷兰内镜检查并发症登记 (DRCE) 的前瞻性收集的数据(2016年1月1日-2019年1月1日)进行分析。为了计算不良事件的发生率,研究人员将数据与内镜检查的服务水平关联在一起。

每个适应症的患者和内镜检查特征

在3年研究期间,DGEA共记录了266981次结肠镜检查。在所有适应症中,粪便免疫化学试验 (FIT) 阳性筛查结肠镜检查的盲肠插管率最高 (97.1%),其次是监测 (93.2%)、诊断 (90.7%) 和治疗性结肠镜检查 (83.1%)。此外,在FIT阳性筛查结肠镜检查中观察到的肠道充分准备率最高 (97.1%)。

不良事件

结肠镜检查后总共发生了1540 次(0.58%)不良事件。治疗性和FIT阳性筛查结肠镜检查的穿孔率和出血率最高(治疗性:分别为0.51%和1.56%;FIT阳性:分别为0.06%和0.72%)。结肠镜检查相关死亡率为0.006%。

综上所述,该研究概述了荷兰国家结肠镜注册的首个分析结果,并将该结果成功地与国家胃肠内镜检查不良事件注册数据相关联。在这项大型数据研究中,性能指标因适应症而异。该研究结果强调了在未来指南中为每个适应症定义基准的重要性。

原始出处:

Nass Karlijn J,van der Schaar Peter J,van der Vlugt Manon et al. Continuous monitoring of colonoscopy performance in the Netherlands: first results of a nationwide registry.[J] .Endoscopy, 2021, https://doi.org/10.1055/a-1556-5914

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1758347, encodeId=6da01e58347a1, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Mon Apr 04 19:01:14 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826715, encodeId=19681826e15b3, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Jul 12 23:01:14 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1434527, encodeId=a8c2143452e85, content=<a href='/topic/show?id=95de81e4889' target=_blank style='color:#2F92EE;'>#肠镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81748, encryptionId=95de81e4889, topicName=肠镜)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Jul 29 14:01:14 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495885, encodeId=dbc7149588551, content=<a href='/topic/show?id=3f696e7069' target=_blank style='color:#2F92EE;'>#endoscopy#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6770, encryptionId=3f696e7069, topicName=endoscopy)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4a39226300, createdName=liuxiaona, createdTime=Thu Jul 29 14:01:14 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003174, encodeId=e64310031e46f, content=关注医学, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Jul 27 23:20:38 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2022-04-04 丁鹏鹏
  2. [GetPortalCommentsPageByObjectIdResponse(id=1758347, encodeId=6da01e58347a1, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Mon Apr 04 19:01:14 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826715, encodeId=19681826e15b3, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Jul 12 23:01:14 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1434527, encodeId=a8c2143452e85, content=<a href='/topic/show?id=95de81e4889' target=_blank style='color:#2F92EE;'>#肠镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81748, encryptionId=95de81e4889, topicName=肠镜)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Jul 29 14:01:14 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495885, encodeId=dbc7149588551, content=<a href='/topic/show?id=3f696e7069' target=_blank style='color:#2F92EE;'>#endoscopy#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6770, encryptionId=3f696e7069, topicName=endoscopy)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4a39226300, createdName=liuxiaona, createdTime=Thu Jul 29 14:01:14 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003174, encodeId=e64310031e46f, content=关注医学, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Jul 27 23:20:38 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1758347, encodeId=6da01e58347a1, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Mon Apr 04 19:01:14 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826715, encodeId=19681826e15b3, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Jul 12 23:01:14 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1434527, encodeId=a8c2143452e85, content=<a href='/topic/show?id=95de81e4889' target=_blank style='color:#2F92EE;'>#肠镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81748, encryptionId=95de81e4889, topicName=肠镜)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Jul 29 14:01:14 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495885, encodeId=dbc7149588551, content=<a href='/topic/show?id=3f696e7069' target=_blank style='color:#2F92EE;'>#endoscopy#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6770, encryptionId=3f696e7069, topicName=endoscopy)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4a39226300, createdName=liuxiaona, createdTime=Thu Jul 29 14:01:14 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003174, encodeId=e64310031e46f, content=关注医学, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Jul 27 23:20:38 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-07-29 zhouqu_8
  4. [GetPortalCommentsPageByObjectIdResponse(id=1758347, encodeId=6da01e58347a1, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Mon Apr 04 19:01:14 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826715, encodeId=19681826e15b3, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Jul 12 23:01:14 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1434527, encodeId=a8c2143452e85, content=<a href='/topic/show?id=95de81e4889' target=_blank style='color:#2F92EE;'>#肠镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81748, encryptionId=95de81e4889, topicName=肠镜)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Jul 29 14:01:14 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495885, encodeId=dbc7149588551, content=<a href='/topic/show?id=3f696e7069' target=_blank style='color:#2F92EE;'>#endoscopy#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6770, encryptionId=3f696e7069, topicName=endoscopy)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4a39226300, createdName=liuxiaona, createdTime=Thu Jul 29 14:01:14 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003174, encodeId=e64310031e46f, content=关注医学, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Jul 27 23:20:38 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1758347, encodeId=6da01e58347a1, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Mon Apr 04 19:01:14 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826715, encodeId=19681826e15b3, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Jul 12 23:01:14 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1434527, encodeId=a8c2143452e85, content=<a href='/topic/show?id=95de81e4889' target=_blank style='color:#2F92EE;'>#肠镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81748, encryptionId=95de81e4889, topicName=肠镜)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Jul 29 14:01:14 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495885, encodeId=dbc7149588551, content=<a href='/topic/show?id=3f696e7069' target=_blank style='color:#2F92EE;'>#endoscopy#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6770, encryptionId=3f696e7069, topicName=endoscopy)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4a39226300, createdName=liuxiaona, createdTime=Thu Jul 29 14:01:14 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003174, encodeId=e64310031e46f, content=关注医学, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Jul 27 23:20:38 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-07-27 SR~young海东

    关注医学

    0

相关资讯

Br J Cancer:质子泵抑制剂PPI的使用影响结直肠癌患者的生存率

质子泵抑制剂(PPI)是全球最常用的处方药之一,在所有成年人中的使用率高达11-30%。

Ann Intern Med:如何通过粪便更精准的筛查结直肠癌?

与FIT相比,mtFIT在检测高级别赘生物方面表现出了更好的诊断准确性

维生素D具有抗癌效果,且在老年时期更明显!

近日发表在BMC Public Health上的一项研究发现,紫外线(UVB)暴露与结肠癌粗发病率之间具有反比关系,且这种关系在老年群体中更为强烈。

Br J Cancer:治疗后炎症相关生物标志物与结直肠癌患者生存之间的关联性研究

炎症反应在结直肠癌(CRC)的发生发展中起着至关重要的作用。